Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

Tumor Myeloid Microenvironment Directed Therapeutics Summit 2021

Evvnt Promotion / evvnt
-
16.03.2021 - 18.03.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temi della conferenza
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/701752-3?pid=4832

Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/701752-0?pid=4832
Ms. Aarti Diwan
 
Categorie
Medicina General, Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 1499.00 - USD 2997.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Swiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzAnästhesie in Entwicklungsländern e. V.Alumni Club Medizinische Universität WienCharité International AcademyÄrzte der WeltÖsterreichische Akademie der Ärzte